Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis

被引：3
|
作者：
Meng, Xiangpeng [1 ]
Ma, Jia [2 ]
Meng, Nan [3 ]
Yun, Tianyu [3 ]
Niu, Beifang [3 ,4 ,5 ]
机构：
[1] China Med Univ, Pancreat Endocrinol Ward, Dept Gen Surg, Shengjing Hosp, Shenyang, Peoples R China
[2] China Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Shenyang, Peoples R China
[3] Beijing ChosenMed Clin Lab Co Ltd, Beijing, Peoples R China
[4] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China
[5] Univ Chinese Acad Sci, Beijing, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
SMARCA4; BRG1; SWI; SNF; gallbladder carcinoma; case report; SMALL-CELL CARCINOMA; SWI/SNF COMPLEX; FANCONI-ANEMIA; PIK3CA MUTATIONS; CANCER; EXPRESSION; OVARY; INHIBITION; RISK; GAIN;
D O I：
10.3389/fonc.2023.1086266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SMARCA4 (BRG1)-deficient undifferentiated carcinoma is a rare and highly aggressive malignancy. It has been reported to occur in a multiple range of organs. However, to the best of our knowledge, SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder has not yet been reported. Here, we describe a case of SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder. Through comprehensive genetic analysis, we hypothesized that in addition to SMARCA4 (BRG1) deficiency, other genetic changes might also be involved in the tumorigenesis of undifferentiated gallbladder cancer in this patient, particularly somatic mutations in the CTNNB1, KRAS, PIK3CA, TP53, CREBBP, and FANCI genes. To the best of our knowledge, this is the first report of SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] SMARCA4 deficient undifferentiated tumor in nasopharynx
    Shi, Mengting
    Chen, Xueyuan
    Liu, Tingting
    Yin, Shasha
    Lin, Zhixiong
    ORAL ONCOLOGY, 2025, 161
  • [22] Loss of Expression of SMARCA4 (BRG1) and SMARCB1 (INI1) in Undifferentiated Carcinoma of the Endometrium Is Not Always Associated with Rhabdoid Morphology
    Ramalingam, Preetha
    Croce, Sabrina
    McCluggage, W. Glenn
    MODERN PATHOLOGY, 2016, 29 : 303A - 303A
  • [23] RHABDOID TUMOR PREDISPOSITION SYNDROME DUE TO MUTATION OF BRG1/SMARCA4
    Fruewaldi, M. C.
    Schneppenheim, R.
    Gesk, S.
    Hasselblatt, Ni.
    Vater, I.
    Kordes, U.
    Leuschner, I.
    Subero, M.
    Obser, T.
    Oyen, F.
    Siebert, R.
    NEURO-ONCOLOGY, 2010, 12 (06) : II63 - II63
  • [24] SMARCA4/BRG1-Deficient Sinonasal Carcinoma Morphologic Spectrum of an Evolving Entity
    Kakkar, Aanchal
    Ashraf, Subiyathul Farah
    Rathor, Amber
    Adhya, Amit Kumar
    Mani, Suresh
    Sikka, Kapil
    Jain, Deepali
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (09) : 1122 - 1143
  • [25] Coinactivation of the Switch/Sucrose Nonfermenting Complex SMARCA4/BRG1 and SMARCB1/INI1 in a Cervical Mixed Carcinoma: A Case Report
    Qi, Yu
    Qi, Peng
    Yao, Qianlan
    Sun, Xiangjie
    Zhou, Xiaoyan
    Bi, Rui
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (06) : 646 - 651
  • [26] Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Montecalvo, Joseph
    Alex, Deepu
    Ptashkin, Ryan
    Ni, Ai
    Sauter, Jennifer L.
    Chang, Jason
    Jungbluth, Achim
    Beras, Amanda
    Namakydoust, Azadeh
    Rudin, Charles
    Ladanyi, Marc
    Antonescu, Cristina R.
    Travis, William
    Rekhtman, Natasha
    LABORATORY INVESTIGATION, 2018, 98 : 742 - 742
  • [27] Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Montecalvo, Joseph
    Alex, Deepu
    Ptashkin, Ryan
    Ni, Ai
    Sauter, Jennifer L.
    Chang, Jason
    Jungbluth, Achim
    Beras, Amanda
    Namakydoust, Azadeh
    Rudin, Charles
    Ladanyi, Marc
    Antonescu, Cristina R.
    Travis, William
    Rekhtman, Natasha
    MODERN PATHOLOGY, 2018, 31 : 742 - 742
  • [28] Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer
    Medina, Pedro P.
    Cespedes, Montse Sanchez
    EPIGENETICS, 2008, 3 (02) : 64 - 68
  • [29] SOX2 and Claudin-4 Are Useful Marker for Differentiating the Undifferentiated Uterine Carcinoma From the Recently Recognized SMARCA4 (BRG1)-Deficient Malignant Rhabdoid Tumor of Uterus
    Aakash, Nfn
    Zhao, Bihong
    Zhu, Hui
    Buryanek, Jamie
    Ding, Jianmin
    Sun, Qigang
    Zhang, Songlin
    LABORATORY INVESTIGATION, 2019, 99
  • [30] SOX2 and Claudin-4 Are Useful Marker for Differentiating the Undifferentiated Uterine Carcinoma From the Recently Recognized SMARCA4 (BRG1)-Deficient Malignant Rhabdoid Tumor of Uterus
    Aakash, Nfn
    Zhao, Bihong
    Zhu, Hui
    Buryanek, Jamie
    Ding, Jianmin
    Sun, Qigang
    Zhang, Songlin
    MODERN PATHOLOGY, 2019, 32
12345